PROGRAM WSTĘPNY


14:00 - 16:50
COVID-19: respiratory failure
Opening ceremony
Pathophysiology of respiratory failure in COVID-19
Non-invasive ventilation in COVID-19
Invasive mechanical ventilation in COVID-19
Prone positon in severe ARDS
Discussion
Feature lecture: Helmet ventilation the “Italian job”
16:30 - 16:45
Break
16:45 - 18:35
Extracorpopreal techniques
The role of extracorporeal blood purification in COVID-19
Therapeutic plasma exchange in sepsis and COVID-19
Utility of cytokine absorbtion in COVID-19
Discussion
Feature lecture: How I set PEEPand VT in severe ARDS
18:35 - 18:50
Break
18:50 - 20:10
COVID-19 - beyond mechanical ventilation
Fluids: when and how in ARDS
Hemostatic monitoring in COVID-19 patients
Discussion
Feature lecture: The ICU system response to the first surge of COVID-19 in Lombardy - a regional ICU network
14:00 - 16:00
Fluid therapy and haemodynamic monitoring
14:00 - 14:20
How I assess tissue hypoxia in a critically ill patient
14:20 - 14:40
How I choose vasoactive and inotropic agents in the management of septic shock
14:40 - 15:00
Short-acting beta-blockers in septic shock: fiction, science or clinical practice?
15:00 - 15:20
Predicting hemodynamic instability: from a reactive to a proactive hemodynamic management
15:20 - 15:40
Appriopriate fluid for appropriate patient - an update
15:40 - 16:00
Discussion
16:00 - 16:15
Break
16:15 - 17:35
Neurologic monitoring in the ICU
16:15 - 16:35
ICP management in TBI
16:35 - 16:55
Neuromonitoring in TBI
16:55 - 17:15
TBI-induced extracerebral organ dysfunction
17:15 - 17:35
Discussion
17:35 - 17:50
Break
17:50 - 18:50
What’s new in intensive care
17:50 - 18:10
Big data and artificial intelligence - a way to go?
18:10 - 18:30
Severe hypoxemia in ARDS patients
18:30 - 18:50
Discussion
08:45 - 09:45
Difficult airway or difficult patient?
08:45 - 09:05
Intubation in critically ill patients - insights from the INTUBE Study
09:05 - 09:25
Difficult airway in the ICU
09:25 - 09:45
Discussion
09:45 - 09:55
Break
09:55 - 10:50
Diversity and equality in the ICU
09:55 - 10:15
Diversity and equality in the ICU: why it matters
10:15 - 10:35
Diversity and equality in the ICU - current status
10:35 - 10:50
Discussion
10:50 - 11:00
Break
11:00 - 12:40
Infections and antimicrobials
11:00 - 11:20
Antibiotic use in patients with COVID-19
11:20 - 11:40
The secondary bacterial infections in COVID-19
11:40 - 12:00
Do not miss viral and fungal infections in COVID-19!
12:00 - 12:20
Antibiotic therapy - how long is perfect?
12:20 - 12:40
Discussion
12:40 - 12:50
Break
12:50 - 14:10
ECMO
12:50 - 13:10
ECMO in COVID-19 patients - patient selection and outcomes
13:10 - 13:30
ECMO in every ICU? - the quest for a perfect model
13:30 - 13:50
ECMO in COVID-19 - Polish experience
13:50 - 14:10
Discussion
14:10 - 14:30
Break
14:30 - 16:10
Working together for a progress in the intensive care
14:30 - 14:50
Response-adaptive multifactorial trial designs in critical care research – the REMAP-CAP experience
14:50 - 15:10
Current management of COVID-19 - the insights from the RECOVERY study
15:10 - 15:30
REMAP-CAP contribution to the treatment of COVID-19
TBD
15:30 - 15:50
Global co-operation for evidence in critical care – why we need platform trials
15:50 - 16:10
Discussion
16:10 - 16:20
Break
16:20 - 17:20
Sesja polska
16:20 - 16:40
Co nowego w intensywnej terapii - przegląd systematyczny najważniejszych badań
16:40 - 17:00
Lekarz w obliczu niedoboru zasobów - aspekty prawne i etyczne
17:00 - 17:20
Dyskusja

Ta strona używa ciasteczek (COOKIES). Zapoznaj się z Polityką prywatności aby dowiedzieć się więcej.
Korzystając ze strony wyrażasz zgodę na używanie cookie, zgodnie z aktualnymi ustawieniami przeglądarki.